- Home
- ECOR vs USAU Comparison
ECOR vs USAU Comparison
Compare ECOR & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- USAU
- Stock Information
- Founded
- ECOR 2005
- USAU N/A
- Country
- ECOR United States
- USAU United States
- Employees
- ECOR N/A
- USAU N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- USAU Precious Metals
- Sector
- ECOR Health Care
- USAU Basic Materials
- Exchange
- ECOR Nasdaq
- USAU Nasdaq
- Market Cap
- ECOR 110.4M
- USAU 109.9M
- IPO Year
- ECOR 2018
- USAU N/A
- Fundamental
- Price
- ECOR $17.67
- USAU $8.51
- Analyst Decision
- ECOR Strong Buy
- USAU Strong Buy
- Analyst Count
- ECOR 1
- USAU 2
- Target Price
- ECOR $25.00
- USAU $11.50
- AVG Volume (30 Days)
- ECOR 104.7K
- USAU 259.3K
- Earning Date
- ECOR 03-12-2025
- USAU 03-17-2025
- Dividend Yield
- ECOR N/A
- USAU N/A
- EPS Growth
- ECOR N/A
- USAU N/A
- EPS
- ECOR N/A
- USAU N/A
- Revenue
- ECOR $23,327,000.00
- USAU N/A
- Revenue This Year
- ECOR $59.81
- USAU N/A
- Revenue Next Year
- ECOR $38.49
- USAU N/A
- P/E Ratio
- ECOR N/A
- USAU N/A
- Revenue Growth
- ECOR 74.10
- USAU N/A
- 52 Week Low
- ECOR $5.32
- USAU $3.29
- 52 Week High
- ECOR $19.49
- USAU $9.85
- Technical
- Relative Strength Index (RSI)
- ECOR 55.62
- USAU 54.23
- Support Level
- ECOR $15.83
- USAU $8.52
- Resistance Level
- ECOR $19.43
- USAU $9.85
- Average True Range (ATR)
- ECOR 1.19
- USAU 0.68
- MACD
- ECOR 0.17
- USAU -0.06
- Stochastic Oscillator
- ECOR 58.06
- USAU 46.40
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.